Literature DB >> 18975058

The effect of molecular weight, drug load, and charge of gelatin-MTX conjugates on growth inhibition of HL-60 leukemia cells.

Chao-Sheng Chen1, Clyde M Ofner.   

Abstract

PURPOSE: Gelatin-methotrexate conjugates (G-MTX) with known molecular weight (MW), drug load, and charge were prepared and evaluated for growth inhibition on leukemia cells.
METHODS: Gelatin (34 to 171 kDa) was reacted with a carbodiimide to prepare G-MTX with high (G-MTX-H) and low (G-MTX-L) drug loads. Cationic conjugates were prepared by ethylenediamine modification. MTX:gelatin molar ratios were determined spectrophotometrically. Isoelectric focusing electrophoresis (IEF) and turbidity were used to measure isoelectric points (IEP). Growth inhibition profiles and IC50 values were determined on HL-60 cells using a modified MTT assay.
RESULTS: IC50 values of anionic G-MTX-L (drug loads 0.5:1 to 2.2:1) increased linearly from 46 to 180 nM with MW. But, IC50 values for anionic G-MTX-H (drug loads 7.4:1 to 25:1) showed little, if any, MW dependence and were about two times higher. IC50 values for cationic G-MTX-L ranged from 770 to 2,900 nM and the relationship with MW was non-linear.
CONCLUSIONS: The growth inhibition ranking was MTX>anionic G-MTX-L>anionic G-MTX-H>cationic G-MTX-L. High drug load may hinder lysosomal enzyme degradation and drug release and contribute to suppression of the MW effect observed with G-MTX-L. A mechanism change is suggested as the cationic conjugates increase to the highest MW.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18975058     DOI: 10.1007/s11095-008-9746-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma.

Authors:  R HERTZ; M C LI; D B SPENCER
Journal:  Proc Soc Exp Biol Med       Date:  1956-11

2.  The effect of the substitution level of some dextran-methotrexate conjugates on their antitumor activity in experimental cancer models.

Authors:  Dmitry Nevozhay; Renata Budzynska; Monika Jagiello; Urszula Kanska; Mohamed Salah Omar; Adam Opolski; Joanna Wietrzyk; Janusz Boratynski
Journal:  Anticancer Res       Date:  2006 May-Jun       Impact factor: 2.480

3.  Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line.

Authors:  T Minko; P Kopecková; J Kopecek
Journal:  J Control Release       Date:  1999-05-20       Impact factor: 9.776

Review 4.  Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials.

Authors:  G S Longo-Sorbello; J R Bertino
Journal:  Haematologica       Date:  2001-02       Impact factor: 9.941

5.  Disposition characteristics of macromolecules in tumor-bearing mice.

Authors:  Y Takakura; T Fujita; M Hashida; H Sezaki
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

6.  The effect of charge on cellular uptake and phototoxicity of polylysine chlorin(e6) conjugates.

Authors:  N S Soukos; M R Hamblin; T Hasan
Journal:  Photochem Photobiol       Date:  1997-04       Impact factor: 3.421

7.  Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.

Authors:  Katja Riebeseel; Elfi Biedermann; Roland Löser; Norbert Breiter; Ralf Hanselmann; Rolf Mülhaupt; Clemens Unger; Felix Kratz
Journal:  Bioconjug Chem       Date:  2002 Jul-Aug       Impact factor: 4.774

Review 8.  The methotrexate story: a paradigm for development of cancer chemotherapeutic agents.

Authors:  F M Huennekens
Journal:  Adv Enzyme Regul       Date:  1994

9.  Effect of molecular size of 125I-labelled poly(vinylpyrrolidone) on its pinocytosis by rat visceral yolk sacs and rat peritoneal macrophages.

Authors:  R Duncan; M K Pratten; H C Cable; H Ringsdorf; J B Lloyd
Journal:  Biochem J       Date:  1981-04-15       Impact factor: 3.857

10.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

View more
  3 in total

1.  Carbodiimide induced cross-linking, ligand addition, and degradation in gelatin.

Authors:  Christopher R Cammarata; Mitchell E Hughes; Clyde M Ofner
Journal:  Mol Pharm       Date:  2015-02-06       Impact factor: 4.939

2.  The effect of molecular weight, drug load, and charge of gelatin-MTX conjugates on growth inhibition of HL-60 leukemia cells.

Authors:  Chao-Sheng Chen; Clyde M Ofner
Journal:  Pharm Res       Date:  2008-10-31       Impact factor: 4.200

3.  Hydroxyethylcellulose as a methotrexate carrier in anticancer therapy.

Authors:  Jarosław Ciekot; Mateusz Psurski; Katarzyna Jurec; Janusz Boratyński
Journal:  Invest New Drugs       Date:  2020-07-08       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.